JB Chemicals & Pharmaceuticals Limited has informed regarding Disclosure under Regulation 30
JBCHEPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Smallcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
JB Chemicals & Pharmaceuticals has received an order from the State Tax Officer (Intelligence), Chennai, under Section 74 of the Goods and Services Act, 2017, imposing a penalty of ₹80.81 lakhs. The order relates to an alleged reversal of tax liability arising from differences between the company's GST returns and its books of accounts for the period April 2019 to March 2020. The company plans to file an appeal against the order and is hopeful of a favorable outcome at the appellate level. Management has stated that the order is not expected to have any material financial impact on the company.
The penalty is small in absolute terms and an appeal is being filed, so this is unlikely to materially affect the stock price or financials. Investors should keep an eye on the appeal outcome, but the disclosed impact appears negligible.